Background: Whereas some studies have demonstrated the essential role of 5-hydroxytryptamine (5-HT) in tramadol and acetaminophen analgesia, other research has presented conflicting results. To dispel doubts, some aspects of the involvement of 5-HT in the antinociceptive properties of these drugs remain to be clarified.
Objectives: The aim of this study was to determine whether the serotoninergic system dysfunction produced by neonatal 5-HT lesion in rats may affect the antinociceptive effects of tramadol and acetaminophen administered in adulthood.
Material And Methods: Three days after birth, the control rats were pretreated with desipramine HCl (20 mg/kg i.p.) 30 min before intraventricular saline--vehicle injection. A separate group received 5.7-DHT; 2×35 µg in each lateral ventricle. At the age of 8 weeks, 5-HT and 5-hydroxyidoleaceticacid (5-HIAA) concentrations were determined in the thalamus and spinal cord by an HPLC/ED method. The antinociceptive effects of tramadol (20 mg/kg i.p.) or acetaminophen (100 mg/kg i.p.) were evaluated by a battery of tests.
Results: 5.7-DHT lesioning was associated with a reduction in 5-HT and 5-HIAA content of the thalamus (>85% and >90%) and spinal cord (>58% and 70%). Neonatal 5.7-DHT treatment produced a significant reduction in the antinociceptive effect of tramadol in the hot plate, tail-immersion, paw withdrawal and writhing tests. In the formalin hind paw test, the results were ambiguous. 5-HT lesion was also associated with a decrease in the analgesic effect of acetaminophen in the hot plate and writhing tests. A similar relationship wasn't found in the other assessments conducted with the use of acetaminophen.
Conclusions: The present study provides evidence that (1) an intact serotoninergic system is required for the adequate antinociceptive action of tramadol, and (2) the serotoninergic system exerts a negligible influence on acetaminophen-induced analgesia in rats. We hypothesize that similar abnormalities in nociception may occur in patients with 5-HT dysfunction (e.g. depression), so these results should be complied in analgesic dosage adjustment.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.17219/acem/23362 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
From Fundamentals to Innovation in Alzheimer's Disease: Molecular Findings and Revolutionary Therapies.
Int J Mol Sci
November 2024
Department of Psychiatry, "Carol Davila" University of Medicine and Pharmacy Bucharest, 020021 Bucharest, Romania.
Alzheimer's disease (AD) is a global health concern and the leading cause of dementia in the elderly. The prevalence of this neurodegenerative condition is projected to increase concomitantly with increased life expectancy, resulting in a significant economic burden. With very few FDA-approved disease-modifying drugs available for AD, there is an urgent need to develop new compounds capable of impeding the progression of the disease.
View Article and Find Full Text PDFA new pharmacological strategy against treatment-resistant depression.
Prog Neuropsychopharmacol Biol Psychiatry
November 2024
Departamento de Fisiología Humana, Facultad de Medicina, Universidad de Málaga, Instituto de Investigación Biomédica de Málaga (IBIMA), Campus de Teatinos s/n, Málaga, Spain. Electronic address:
Major depressive disorder affects more than 50 million people in the world. However, 50% of patients don't respond to two or more drugs or psychotherapeutic treatments, named treatment-resistant depression (TRD). In this work, we propose a new augmentation treatment against TRD based on combining Fluoxetine (FLX) and the N-terminal fragment Galanin, GAL(1-15).
View Article and Find Full Text PDFEffects of lateral ventricle injection of 5,7-dihydroxytryptamine on neurons in the medial prefrontal cortex of rats: An electrophysiology study.
Neurosci Lett
January 2025
College of Basic Medicine and Forensic Medicine, Henan University of Science and Technology, Luoyang 471023, China.
The medial prefrontal cortex (mPFC) is closely associated with various psychopathologies in humans, and its dysfunction is invariably accompanied by abnormalities in the serotonin (5-hydroxytryptamine, 5-HT) system of the brain. In this study, in-vivo extracellular recording techniques were used to investigate changes in the excitability of pyramidal neurons and interneurons in the rat mPFC following injection of 5,7-dihydroxytryptamine (5,7-DHT) into the bilateral lateral ventricles to damage the serotoninergic neurons. The levels of 5-HT in the mPFC and dorsal raphe nucleus of rats were determined by high-performance liquid chromatography.
View Article and Find Full Text PDFEffects of serotonergic manipulation in the brainstem and hypothalamus of overnourished rats during lactation.
Life Sci
December 2024
Postgraduate Program in Neuropsychiatry and Behavior Science, Federal University of Pernambuco - UFPE, Recife, PE, Brazil; Postgraduate Program in Biochemistry and Physiology, Federal University of Pernambuco -UFPE, Recife, PE, Brazil; Graduate Program in Nutrition, Physical Activity, and Phenotypic Plasticity, Federal University of Pernambuco-UFPE, Vitória de Santo Antão, PE, Brazil. Electronic address:
Article Synopsis
- Previous research indicates that being overweight or obese can disrupt brain function during critical developmental phases, but more studies are needed on how immediate overnutrition affects serotonin in the brain.
- This study investigates how altering serotonin levels with fluoxetine treatment in overnourished rats impacts oxidative stress and inflammatory markers in their brainstem and hypothalamus.
- Findings suggest that overnutrition in early life leads to harmful changes in brain chemistry, but fluoxetine treatment can counteract some of these negative effects, supporting healthier brain development.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!